| Costimulation through TLR2 drives polyfunctional CD8+ T cell responses JJ Freen-van Heeren, F Salerno, A Guislain, BP Nicolet, MC Wolkers Journal of Immunology 202 (3), 714-723, 2019 | 58 | 2019 |
| Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile R de Groot, MM van Loenen, A Guislain, BP Nicolet, JJ Freen-van Heeren, ... OncoImmunology 8 (11), e1648170, 2019 | 47 | 2019 |
| Critical role of post-transcriptional regulation for IFN-γ in tumor-infiltrating T cells F Salerno, A Guislain, JJ Freen-van Heeren, BP Nicolet, HA Young, ... OncoImmunology 8 (2), e1532762, 2019 | 39 | 2019 |
| Using CRISPR to enhance T cell effector function for therapeutic applications JJ Freen-van Heeren Cytokine: X 3 (1), 100049, 2021 | 25 | 2021 |
| Human T cells employ conserved AU-rich elements to fine-tune IFN-γ production JJ Freen-van Heeren, B Popović, A Guislain, MC Wolkers European Journal of Immunology 50 (7), 949-958, 2020 | 25 | 2020 |
| Measuring T cell responses by flow cytometry–based fluorescence in situ hybridization JJ Freen-van Heeren, BP Nicolet, MC Wolkers Critical Reviews in Immunology 38 (2), 131–143, 2018 | 15 | 2018 |
| Combined Single-Cell Measurement of Cytokine mRNA and Protein in Immune Cells JJ Freen-van Heeren, BP Nicole, MC Wolkers Methods in Molecular Biology 2108, 259-271, 2020 | 13 | 2020 |
| Toll‐like receptor‐2/7‐mediated T cell activation: an innate potential to augment CD8+ T cell cytokine production JJ Freen-van Heeren Scandinavian Journal of Immunology 93 (5), e13019, 2020 | 12 | 2020 |
| Flow-FISH as a tool for studying bacteria, fungi and viruses JJ Freen-van Heeren BioTech 10 (4), 21, 2021 | 11 | 2021 |
| Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV JJ Freen-van Heeren BioTech 11 (3), 25, 2022 | 10 | 2022 |
| Time-dependent regulation of cytokine production by RNA binding proteins defines T cell effector function B Popović, BP Nicolet, A Guislain, S Engels, AP Jurgens, N Paravinja, ... Cell Reports 42 (5), 112419, 2023 | 8 | 2023 |
| Post‐transcriptional control of T cell cytokine production: implications for cancer therapy JJ Freen-van Heeren Immunology 164 (1), 57-72, 2021 | 6 | 2021 |
| Addressing HIV-1 Latency with Flow-FISH: Finding, Characterizing and Targeting HIV-1 Infected Cells JJ Freen-van Heeren Cytometry: Part A 99 (9), 861-865, 2021 | 5 | 2021 |
| Memory CD8+ T cells upregulate glycolysis and effector functions under limiting oxygen conditions A Beumer-Chuwonpad, FJ van Alphen, NAM Kragten, ... European Journal of Immunology 53 (2), 2249918, 2023 | 2 | 2023 |
| Exploiting HIV-1 tropism to target CD4+ T cells for CRISPR JJ Freen-van Heeren Immunology & Cell Biology 99 (7), 677-679, 2021 | 2 | 2021 |
| Harnessing High-Throughput Flow Cytometric Protein and RNA Detection to Enhance TIL Therapy JJ Freen-van Heeren Cytometry: Part A 99 (8), 766-768, 2021 | 2* | 2021 |
| CLASH of the Titans:How CAR-T Cells Can Triumph Over Tumors R Opstelten, JJ Freen-van Heeren The CRISPR Journal 6 (2), 87-89, 2023 | 1 | 2023 |
| Age is just a number: long-lasting T-cell immunity can span several lifetimes JJ Freen-van Heeren, R Opstelten Immunology & Cell Biology 101 (5), 374-376, 2023 | 1 | 2023 |
| FISHing for COVID-19: Studying SARS-CoV-2 With Single-Molecule FISH and Flow-FISH JJ Freen van Heeren Cytometry: Part A 103 (2), 107-109, 2023 | 1 | 2023 |
| Investigating EBV biology with Flow-FISH: implications for EBV-mediated malignancies and the treatment thereof JJ Freen-van Heeren Cytometry: Part A 103 (1), 5-7, 2023 | 1 | 2023 |
